About Hopital Prive Drome Ardeche; Hopital De Jour
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at Hopital Prive Drome Ardeche; Hopital De Jour
During the past decade, Hopital Prive Drome Ardeche; Hopital De Jour conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
2018-08-02
2025-08-24
Active, not recruiting
2,300
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Prive Drome Ardeche; Hopital De Jour"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Hopital Prive Drome Ardeche; Hopital De Jour
According to Clinical.Site data, the most researched conditions in "Hopital Prive Drome Ardeche; Hopital De Jour" are
"Breast Neoplasms" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Hopital Prive Drome Ardeche; Hopital De Jour" in a lesser frequency.
Clinical Trials Intervention Types at Hopital Prive Drome Ardeche; Hopital De Jour
Most popular intervention types in "Hopital Prive Drome Ardeche; Hopital De Jour" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (2 trials), "Atezolizumab" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials) and "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hopital Prive Drome Ardeche; Hopital De Jour
The vast majority of trials in "Hopital Prive Drome Ardeche; Hopital De Jour" are
2 trials for "All" genders.
Clinical Trials Status at Hopital Prive Drome Ardeche; Hopital De Jour
Currently, there are NaN active trials in "Hopital Prive Drome Ardeche; Hopital De Jour".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Hopital Prive Drome Ardeche; Hopital De Jour,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Prive Drome Ardeche; Hopital De Jour, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".